Acted for Life Science REIT as Nominated Adviser, Joint Global Co-Ordinator & Joint Bookrunner on its £350m IPO and Placing, Offer for Subscription and Intermediaries Offer
November 2021
Panmure Gordon acted as Nominated Adviser, Joint Global Co-Ordinator & Joint Bookrunner on the IPO of Life Science REIT plc.
- Offer price of 100p/£350m market cap on admission
- Life Science REIT plans to invest in a diversified portfolio of properties across the UK in key life sciences clusters
- Admission to Trading on the AIM market of the London Stock Exchange took place on 19 November 2021
- Global Co-Ordinator
- Joint Bookrunner with Jefferies
- Upscaled oversubscribed primary raise from an initial target of £300m
- This was the largest REIT IPO in the UK since 2016
- 87 1×1 investor meetings, of which 48 were arranged by Panmure
- 4 large group calls, reaching 114 separate institutions
- In total, Panmure engaged with 77 institutions during the process